Pathology specialist contributes to debate on breast cancer gene screening

What are the risks and benefits of screening for BRCA1 and BRCA2 mutations in the general adult population? An expert has published an invited commentary on this issue. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *